• About
  • Advertise
  • Testimonials
  • Contact
Tuesday, 19 February, 2019
No Result
View All Result
OpenGov Asia
SUBSCRIBE
  • Channels
    • Augmented Intelligence
    • Big data
    • Cloud
    • Cyber Resilience
    • Digital Economy
    • Digital Transformation
    • Education
    • FSI/Fintech
    • Healthcare
    • IoT
    • Mobility
    • Open Data
    • Public Safety
    • All
  • Countries
    • Australia
    • China
    • Global
    • Hong Kong
    • India
    • Indonesia
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • Taiwan
    • Thailand
    • Vietnam
  • Events
  • Expert Opinions
  • Awards
  • White Papers
  • Channels
    • Augmented Intelligence
    • Big data
    • Cloud
    • Cyber Resilience
    • Digital Economy
    • Digital Transformation
    • Education
    • FSI/Fintech
    • Healthcare
    • IoT
    • Mobility
    • Open Data
    • Public Safety
    • All
  • Countries
    • Australia
    • China
    • Global
    • Hong Kong
    • India
    • Indonesia
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • Taiwan
    • Thailand
    • Vietnam
  • Events
  • Expert Opinions
  • Awards
  • White Papers
No Result
View All Result
OpenGov Asia
No Result
View All Result
  • Channels
    • Augmented Intelligence
    • Big data
    • Cloud
    • Cyber Resilience
    • Digital Economy
    • Digital Transformation
    • Education
    • FSI/Fintech
    • Healthcare
    • IoT
    • Mobility
    • Public Safety
    • All
  • Events
  • Expert Opinions
  • White Papers
Home Digital Transformation

HKBU scholars announce revolutionary new biotechnology

University’s scholars develop first-ever system for rapid antibiotic resistance testing and analysis.

by Alita Sharon
18 January, 2019
in Digital Transformation, Healthcare, Hong Kong, News
HKBU scholars announce revolutionary new biotechnology

HKBU, Press Release

8
SHARES
23
VIEWS
Share on LinkedInShare on Twitter

According to a recent press release, researchers from the Department of Chemistry at Hong Kong Baptist University (HKBU) have invented the world’s first multidimensional antimicrobial susceptibility testing (AST) system.

The new technology can provide information about drug resistant pathogens present in patients, enabling doctors to accurately determine the effectiveness and appropriate dosage of antibiotics needed for effective treatment.

The new fully-automated system is 10-20 times faster, more accurate and can also be run at a much lower cost than the current AST methods which are only available in professional medical laboratories.

It is expected that the invention will aid diagnosis by providing doctors with a precise prescription which will significantly reduce the chance of antibiotic abuse or misuse. The team is planning to commercialise the system so that more people can benefit from the development.

In order to accurately test and analyse antibiotic resistance, the team fabricated a hydrogel microfluidic chip which simulates the drug diffusion process and the killing of pathogenic bacteria inside the human body. The system is simple to operate and only requires a small amount of the patient’s body fluid, such as blood or saliva. Once unwanted substances have been removed, the sample fluid is placed on the chip, and is then treated with different antibiotics.

After about four hours, the system indicates the effectiveness of the antibiotic treatment and whether it is needed. Due to the chip’s multidimensional properties, multiple variables can be introduced simultaneously, such as different antibiotics, nutrients and immunologic substances. Automated microscopic observation of bacterial growth also enables users to determine the most appropriate type, or the best combination, of different types of antibiotics and the required dosage for treatment.

The Assistant Professor at HKBU’s Department of Chemistry noted that, currently, clinical doctors assess a patient’s suspected bacterial infections according to their experience. They then decide whether to prescribe antibiotics, tailoring the treatment and type of antibiotic to be applied accordingly.

If the patient does not recover having taken the medicine, the doctor will reassess or use another antibiotic. Currently there are ASTs available for doctors to assess the patients’ antimicrobial susceptibility but it takes a few days to obtain the results.

As a result, the current treatment process is not only time-consuming and inefficient, but can also stimulate antimicrobial resistance due to misuse or overuse of antibiotics. Moreover, doctors usually prescribe broad-spectrum antibiotics to speed-up treatment times and target a wide-range of different bacteria. This broad-spectrum approach can also kill harmless bacteria, accelerating antibiotic resistance in pathogens and affecting the long-term health of patients.

It was noted that the new method can analyse bacterial morphology and quantity under the microscope. It takes only four hours to obtain accurate AST data, and with this new method the treatment process can be faster and more accurate.

Doctors will first evaluate the patient and then analyse a small amount of their body fluid using the new system. Based on the results, the antibiotic (or a combination thereof) with the lowest susceptibility, the best efficacy, and the most appropriate dosage will be selected for the patient.

Hence, better therapeutic performance can be achieved. Moreover, the rate of the development of antibiotic resistance can also be slowed down.

As the new system employs microfluidic technology, compared with the existing AST methods, its accuracy is not only higher, but it also requires much smaller samples and takes significantly less time to carry out tests.

In addition, the synergistic effects of multiple drugs and the dynamic changes of different substances in the human body can also be simulated. The ability to automate the test can reduce possible errors from human manipulation and observation too.

Quoting a World Health Organization (WHO) report, the Assistant Professor noted that if humans do not take timely countermeasures, antimicrobial resistance will gradually accelerate. The WHO estimates that around 300 million people will die due to drug-resistant microbes in 2050, leading to serious economic losses around the world.

The development of new antibiotics takes an average of 10 to 20 years, in addition to the large amount of money required. Existing antibiotics have also begun to weaken or even fail to kill some bacteria. This new method can slow down the process of antimicrobial resistance and help to prevent the formation of “superbugs”.

At the same time, Dr Ren expects that the new system could be used to collect information about antimicrobial resistance, which would facilitate big data analysis and support the development of new antibiotics.

Next Post
Re-using plastic waste to produce 3D printing filaments

Re-using plastic waste to produce 3D printing filaments

Recommended

Smart Transportation and Smart Energy Combine to Electrify our Future

Smart Transportation and Smart Energy Combine to Electrify our Future

12 February, 2019
Hong Kong will focus on cybersecurity in 2019

Hong Kong will focus on cybersecurity in 2019

14 February, 2019
New Zealand’s Business Tech Trends in 2019

New Zealand’s Business Tech Trends in 2019

13 February, 2019
Malaysian state seeks greater investment in GreenTech

Malaysian state seeks greater investment in GreenTech

12 February, 2019

Popular News

  • The current state of cyber security in India

    The current state of cyber security in India

    15 shares
    Share 15 Tweet 0
  • Only 25 countries well-positioned to benefit from Industry 4.0 according to new World Economic Forum report

    4 shares
    Share 4 Tweet 0
  • Singapore releases first Artificial Intelligence (AI) Governance Framework in Asia

    91 shares
    Share 37 Tweet 23
  • The Singapore Management University launches courses to upskill workers in digital technologies

    103 shares
    Share 53 Tweet 21

Newsletter

OpenGov releases new digital content daily on trending topics within technology and the public sector. Join our newsletter to have weekly digests of our content conveniently sent to your email address.

 SUBSCRIBE

Channels

  • Augmented Intelligence
  • Big data
  • Cloud
  • Cyber Resilience
  • Digital Economy
  • Digital Transformation
  • Education
  • FSI/Fintech
  • Healthcare
  • IoT
  • Mobility
  • Open Data
  • Public Safety
  • All

OpenGov Asia

  • About
  • Testimonials
  • Advertise
  • Career
  • Cookies Policy
  • Privacy Policy
  • Contact

About Us

OpenGov is a content platform, dedicated to sharing ICT-related knowledge and information between governments. We focus on the public sector in the Asia-Pacific region. We help governments become more Efficient, Agile, Transparent and Secure, so as to improve the lives of their citizens.

  • About
  • Testimonials
  • Advertise
  • Career
  • Cookies Policy
  • Privacy Policy
  • Contact

© 2019 OpenGov Asia - CIO Network Pte Ltd.
Made with by BrandMolecule.

No Result
View All Result
  • Channels
    • Augmented Intelligence
    • Big data
    • Cloud
    • Cyber Resilience
    • Digital Economy
    • Digital Transformation
    • Education
    • FSI/Fintech
    • Healthcare
    • IoT
    • Mobility
    • Open Data
    • Public Safety
    • All
  • Countries
    • Australia
    • China
    • Global
    • Hong Kong
    • India
    • Indonesia
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • Taiwan
    • Thailand
    • Vietnam
  • Events
  • Expert Opinions
  • Awards
  • White Papers

© 2019 OpenGov Asia - CIO Network Pte Ltd.
Made with by BrandMolecule.